Paul Cutler

Roche (Switzerland) — Switzerland

Medicine · Health Sciences

35h-index5.3kcitations109works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(27), Advanced Proteomics Techniques and Applications(17), Radiopharmaceutical Chemistry and Applications(12), Advanced MRI Techniques and Applications(8), Radiation Detection and Scintillator Technologies(8)

Publications109 total

Relative Quantification of Proteins in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissue Using Multiplexed Mass Spectrometry Assays
Molecular & Cellular Proteomics·2022· 7 citedOpen Access
Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics
Drug Metabolism and Disposition·2021· 43 citedOpen Access
Development of a Highly Multiplexed SRM Assay for Biomarker Discovery in Formalin-Fixed Paraffin-Embedded Tissues
Methods in molecular biology·2019· 5 cited
A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate
PLoS ONE·2017· 29 citedOpen Access
Chapter 3. Targeted Proteomics to Support Transporter IVIVE and PBPK
2016· 3 cited
Cardiac Metabolic Pathway Remodelling in Response to Sunitinib Malate: Potential Role for Positron Emission Tomography in the Cardio-Oncology Setting
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)·2016
Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin‐6 receptor‐alpha inhibition with tocilizumab
PROTEOMICS - CLINICAL APPLICATIONS·2015· 15 cited
The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?
PLoS ONE·2015· 29 citedOpen Access
Proteomics in Pharmaceutical Research and Development
PROTEOMICS - CLINICAL APPLICATIONS·2015Open Access
Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues
Molecular & Cellular Proteomics·2015· 45 citedOpen Access
Identification of six cell surface proteins for specific liver targeting
PROTEOMICS - CLINICAL APPLICATIONS·2015· 16 cited
The human autoantibody response to apolipoprotein A-I is focused on the C-terminal helix: A new rationale for diagnosis and treatment of cardiovascular disease?
Atherosclerosis·2015· 2 cited
Proteomics in pharmaceutical research and development
PROTEOMICS - CLINICAL APPLICATIONS·2015· 9 cited
Characterization of a human pluripotent stem cell‐derived model of neuronal development using multiplexed targeted proteomics
PROTEOMICS - CLINICAL APPLICATIONS·2015· 21 cited
The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug development
PROTEOMICS - CLINICAL APPLICATIONS·2015· 29 cited
supplementary table 5 MSstats, clustering results and correlation with brain mRNA
2015
Supplementary table 6. Correlation of brain mRNA and in vitro protein data
2015
Supplementary table 3 peptide summary
2015
Supplementary table 2 SRM transition list (TSQ Vantage iSRM)
2015
Biomarkers for cardiovascular risk assessment in autoimmune diseases
PROTEOMICS - CLINICAL APPLICATIONS·2014· 10 cited
page 1 of 6Next →

Frequent Co-authors

Carolyn J. Anderson(7), Sally W. Schwarz(6), W.M. Digby(5), E.J. Hoffman(4), Jason S. Lewis(4), Mark Skehel(4), Axel Ducret(4), Jens Lamerz(4), Laura A. Bass(3), Michael J. Welch(3), Gordon W. Philpott(3), Judith M. Connett(3), Mai Xu(3), W.K. Luk(3), Klaus Schneider(3), Ian R. White(3), John Wood(3), John B. Davis(3), Aki T. Heikkinen(3), Arno Friedlein(3)